Endoglin/CD 105 may not be an optimal tumor endothelial treatment target [1]

Breast Cancer Research and Treatment

Volumn 39, Issue 2, 1996, Pages 239-240

  Griffioen, A W ^a   Damen, C A ^a   Blijham, G H ^a   Groenewegen, G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN;

ANTIGEN RECOGNITION; BREAST CANCER; CELL ADHESION; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LETTER; MACROPHAGE; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0029788738     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806191     Document Type: Letter

References (0)